- March 12, 2021
- Category: Drugs and Therapeutics, Healthcare and LifeSciences
Global Ophthalmic Eye Drops Market Size study, by Type (Antibiotics, Artificial Tears, Hormones, Others) by Application (Eye diseases, Eyecare, Others) By Purchase Mode (Prescription, OTC), By Eye Diseases (Dry Eye, Glaucoma, Conjunctivitis, Refractive Errors, Others) and Regional Forecasts 2021-2027.
Chapter 1.Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2028 (USD Billion) 1.2.1. Ophthalmic Eye Drops Market, by Region, 2019-2028 (USD Billion) 1.2.2. Ophthalmic Eye Drops Market, by Type, 2019-2028 (USD Billion) 1.2.3. Ophthalmic Eye Drops Market, by Application, 2019-2028 (USD Billion) 1.2.4. Ophthalmic Eye Drops Market, by Purchase mode, 2019-2028 (USD Billion) 1.2.5. Ophthalmic Eye Drops Market, by Eye diseases, 2019-2028 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Global Ophthalmic Eye Drops Market Definition and Scope 1.6. The objective of the Study 1.7. Market Definition & Scope 1.7.1. Scope of the Study 1.7.2. Industry Evolution 1.8. Years Considered for the Study 1.9. Currency Conversion Rates Global Ophthalmic Eye Drops Market Dynamics 1.10. Ophthalmic Eye Drops Market Impact Analysis (2019-2028) 1.10.1. Market Drivers 188.8.131.52. Increase in the number of working populations 184.108.40.206. Hormone imbalance 1.10.2. Market Challenges 220.127.116.11. Lack of health insurance for ophthalmology 18.104.22.168. Covid 19 Pandemic 1.10.3. Market Opportunities 22.214.171.124. Soaring cases of eye infections Global Ophthalmic Eye Drops Market Industry Analysis 1.11. Porter’s 5 Force Model 1.11.1. Bargaining Power of Suppliers 1.11.2. Bargaining Power of Buyers 1.11.3. The threat of New Entrants 1.11.4. Threat of Substitutes 1.11.5. Competitive Rivalry 1.11.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028) 1.12. PEST Analysis 1.12.1. Political 1.12.2. Economical 1.12.3. Social 1.12.4. Technological 1.13. Investment Adoption Model 1.14. Analyst Recommendation & Conclusion Global Ophthalmic Eye Drops Market, by Type 1.1. Market Snapshot 1.2. Global Ophthalmic Eye Drops Market by Type, Performance - Potential Analysis 1.3. Global Ophthalmic Eye Drops Market Estimates & Forecasts by Type 2018-2028 (USD Billion) 1.4. Ophthalmic Eye Drops Market, Sub Segment Analysis 1.4.1. Antibiotics, 1.4.2. Artificial Tears, 1.4.3. Hormones, 1.4.4. Others Global Ophthalmic Eye Drops Market, by Application 1.5. Market Snapshot 1.6. Global Ophthalmic Eye Drops Market by Application, Performance - Potential Analysis 1.7. Global Ophthalmic Eye Drops Market Estimates & Forecasts by Application 2018-2028 (USD Billion) 1.8. Ophthalmic Eye Drops Market, Sub Segment Analysis 1.8.1. Eye diseases 1.8.2. Eyecare, 1.8.3. Others Global Ophthalmic Eye Drops Market, by Purchase mode 1.9. Market Snapshot 1.10. Global Ophthalmic Eye Drops Market by Purchase Mode, Performance - Potential Analysis 1.11. Global Ophthalmic Eye Drops Market Estimates & Forecasts by Purchase Mode 2018-2028 (USD Billion) 1.12. Ophthalmic Eye Drops Market, Sub Segment Analysis 1.12.1. Prescription 1.12.2. OTC Global Ophthalmic Eye Drops Market, by Eye disease 1.13. Market Snapshot 1.14. Global Ophthalmic Eye Drops Market by Eye disease, Performance - Potential Analysis 1.15. Global Ophthalmic Eye Drops Market Estimates & Forecasts by Eye disease 2018-2028 (USD Billion) 1.16. Ophthalmic Eye Drops Market, Sub Segment Analysis 1.16.1. Dry Eye 1.16.2. Glaucoma 1.16.3. Conjunctivitis 1.16.4. Refractive Errors 1.16.5. Others Global Ophthalmic Eye Drops Market, Regional Analysis 1.17. Ophthalmic Eye Drops Market, Regional Market Snapshot 1.18. North America Ophthalmic Eye Drops Market 1.18.1. U.S. Ophthalmic Eye Drops Market 126.96.36.199. Type breakdown estimates & forecasts, 2018-2028 188.8.131.52. Application breakdown estimates & forecasts, 2018-2028 184.108.40.206. Purchase mode breakdown estimates & forecasts, 2018-2028 220.127.116.11. Eye Disease breakdown estimates & forecasts, 2018-2028 1.18.2. Canada Ophthalmic Eye Drops Market 1.19. Europe Ophthalmic Eye Drops Market Snapshot 1.19.1. U.K. Ophthalmic Eye Drops Market 1.19.2. Germany Ophthalmic Eye Drops Market 1.19.3. France Ophthalmic Eye Drops Market 1.19.4. Spain Ophthalmic Eye Drops Market 1.19.5. Italy Ophthalmic Eye Drops Market 1.19.6. Rest of Europe Ophthalmic Eye Drops Market 1.20. Asia-Pacific Ophthalmic Eye Drops Market Snapshot 1.20.1. China Ophthalmic Eye Drops Market 1.20.2. India Ophthalmic Eye Drops Market 1.20.3. Japan Ophthalmic Eye Drops Market 1.20.4. Australia Ophthalmic Eye Drops Market 1.20.5. South Korea Ophthalmic Eye Drops Market 1.20.6. Rest of Asia Pacific Ophthalmic Eye Drops Market 1.21. Latin America Ophthalmic Eye Drops Market Snapshot 1.21.1. Brazil Ophthalmic Eye Drops Market 1.21.2. Mexico Ophthalmic Eye Drops Market 1.22. Rest of The World Ophthalmic Eye Drops Market Competitive Intelligence 1.23. Top Market Strategies 1.24. Company Profiles Pfizer Inc. 18.104.22.168. Key Information 22.214.171.124. Overview 126.96.36.199. Financial (Subject to Data Availability) 188.8.131.52. Product Summary 184.108.40.206. Recent Developments 1.24.2. Akorn consumer health 1.24.3. Johnson and Johnson 1.24.4. Prestige Consumer Healthcare 1.24.5. Sagar Pharma Kft. 1.24.6. Maya Biotech 1.24.7. Jawa Pharmaceuticals Ltd 1.24.8. Neiss Labs ltd Research Process 1.25. Research Process 1.25.1. Data Mining 1.25.2. Analysis 1.25.3. Market Estimation 1.25.4. Validation 1.25.5. Publishing 1.26. Research Attributes 1.27. Research Assumption
Global Ophthalmic Eye Drops Market is valued at approximately USD 34.50 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.4% over the forecast period 2021-2027. Ophthalmic Eye drops are used to relieve people suffering from various eye problems such as eye dryness, redness, infection (pink eye), allergies, itching, soreness, swelling, and others. An increase in the number of working populations is also leading to several forms of illness including hormonal disbalances. Imbalance in hormone levels also leads to eye and vision problems. Thus, eye drops and lubricants come to the rescue as they are handier, less painful, and are can be used for various eye problems. The National Ambulatory Medical Care Survey indicated that Americans made more than 4 million visits to ambulatory physicians for bacterial conjunctivitis in 2005. Approximately 70% of patients with acute conjunctivitis present to primary and urgent care providers, which accounts for 1% of all primary care office visits. Adenoviruses account for 65 to 90% of cases of viral conjunctivitis. The report presents a positive growth outlook, ongoing restrictions amid the COVID-19 outbreak might hamper sales.
COVID-19 pandemic is expected to negatively impact the ophthalmic eye drops market. Significant reduction in physician office visits and subsequent decline in the number of prescriptions and OTC eye drop purchases are expected to hamper the market growth during the COVID-19 pandemic. Speedy vaccination programs against COVID are expected to enable market recovery in the coming 1-2 years. Lack of health insurance amongst the population especially within the developing countries or lack of insurance covering all types of IOLs or contact lens in developed countries is a significant challenge faced by the ophthalmology industry. The other challenges include low awareness about ophthalmic disorders, especially in developing countries. This is primarily due to the lack of awareness amongst the rural population about the various ophthalmic disorders such as cataracts. Also, the soaring cases of eye infections have been driving ophthalmic eye drops sales which are likely to increase the market growth during the forecast period.
The regional analysis of the global Ophthalmic Eyedrops market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increase in the prevalence of Glaucoma, cataract, and other ophthalmic disorders. Whereas, Asia-Pacific is also anticipated to exhibit the highest CAGR over the forecast period 2021-2027. Factors such as the rapid rise in the development of health care infrastructure, rise in the incidence of ophthalmic disorders, and increase in initiatives by its government would create lucrative growth prospects for the Global Ophthalmic Eye Drops Market across the Asia-Pacific region.
Major market player included in this report are:
Akorn consumer health
Johnson & Johnson
Prestige Consumer Healthcare
Sagar Pharma Kft.
Jawa Pharmaceuticals ltd
Neiss Labs Ltd
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Purchase Mode :
By Eye Diseases:
Rest of the World
Furthermore, the years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2028
Target Audience of the Global Urgent Care Centers Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers